 Home > Medical News >

Medical Research Articles

European Commission approves head Novartis Luxturna for treatment of hereditary retinal disease

 Time of Update: 2020-06-10

uranium group number omega 3 uses complete control adeno blindness genetic

, Swiss Pharmaceuticals (http:// giant Novartis announced that the European Commission (EC) has approved Luxturna (voretigene neparvoc) to restore and improve vision for children and adults who ha
CHMP recommends approval of Tecentriq in combination with amatin and chemotherapy for first-line treatment in Patients with NSq NSCLC

 Time of Update: 2020-06-10

what study abroad si group inc 10 plus tumor cell markers cobalt cancer treatment

recently, Swiss pharmaceutical (http:// giant Roche announced that the European Medicines (http:// Authority (http:// (http:// Products for human medicine (http:// ) (http:// has issued an
FDA accepts application for license for bioproducts to prevent migraines

 Time of Update: 2020-06-10

hot food temperature binding company bromelain food finger food lunch healthy food guide

recently, the of the of the of food and drugs (the http:// http:// ) of the U.S Food and Drug (http:// has accepted an application for licensing of bioproducts (BLA ) for migraine prevention
Lilly IL-17A inhibitor Taltz (ixekizumab) Phase 3 clinical trial reaches primary endpoint and all important secondary endpoints

 Time of Update: 2020-06-10

menkes disease symptoms autism clinical trials fda approved probiotics 3 types contamination guardian drug company

axial spinal arthritis (axSpA) is a chronic inflammatory disease that mainly affects the shin joints and axial bones, with approximately 4.5 million adult patients worldwide today, Lilly (http://
FDA approves treatment for multiple peripheral neuropathy -- Onpattro (patisiran)

 Time of Update: 2020-06-10

2 3 table structure determines function 1 3 dichlorobenzene kinetic research group protein secondary structure prediction

recent, the United States The FDA (http:// approved the first treatment for multiple peripheral peripheral neuropathy caused by hATTR, npattro (patisiran) About npattro ( is the first fda-appr
The smoking cessation drug AXS-05 reaches its main endpoint in the course of smoking cessation

 Time of Update: 2020-06-10

medicine identification united states nervous system tissue effects smoking pesticides lithium group number nicotine acetylcholine

tobacco dependence is a chronic, highly recurrent disease The World Health Organization has included tobacco dependence as a disease in the International Classification of Diseases, recognizing that
CHMP recommends approval to expand anindications for amp; Aprincyto single-drug treatment

 Time of Update: 2020-06-10

leukemia all immune system nutrition cd45 positive cells immunotherapy cancer factors 22

recently, the European Medicines (http:// Administration (EMA) human Medicines (http:// Product (http:// Committee (CHMP) has issued a positive opinion recommending approval to extend the an
MHLW approves Novartis Kymriah (tisagenlecleucel) for treatment of 2 different indications

 Time of Update: 2020-06-10

plasma cell tumor blood cells microscope car battery cells foods genetically modified protein

recently, Novartis, the Swiss Pharmaceutical (http:// giant, announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Kymriah (tisagenleleucel) for treatment of two diffe
FDA accelerates approval of Vitrakvi (larotrectinib) for treatment of late-stage or metastatic solid tumors

 Time of Update: 2020-06-10

cancer amiodarone drug interactions china white drug drug cat mdt drug

protomyglobulin receptor kinase (TRK) fusion tumors, the NTRK gene merges with unrelated genes, leading to the production of mutated TRK proteins today, Loxo Oncology and Bayer (http:// jointly
Aisi asked EMA for approval of the anti-epileptic drug Fycompa ® (Verumpanai) for the treatment of children with epilepsy

 Time of Update: 2020-06-10

epilepsy awareness day gbl drug sale 2 4 application laboratory sale all states lighting

today, Aishi announced that it has submitted an application to the European Medicines (http:// Authority (EMA) for approval of the use of the anti-epileptic drug (http:// Fycompa ® (Verumpana)
Jansen Pharmaceuticals submits Darzalex (Daratumumab) Class II change request to EMA

 Time of Update: 2020-06-10

parenteral drug ziac drug circulating tumor cells 3 types gas drug discovery process

recently, Johnson and Johnson's Janssen Pharmaceutical (http:// announced a Class II change application to the European Drug (http:// Authority (EMA) for approval of darzalex (Daratumab) in co
FDA approves New Drug Application for Duchesnay Inc. Osphena (aspemifene)

 Time of Update: 2020-06-10

estrogen blocker women severe hangover symptoms excessive vaginal lubrication new age cryo drug inc show

recently, The u.S Food and (http:// ) http:// Administration of medicines (http:// has approved its application for a new http:// of Osphena (aspemifene, opemifen) for the treatment of mode
FDA approves launch of antiviral therapy Dovato developed by ViiV Healthcare

 Time of Update: 2020-06-10

drug disease number 1 copper morgellons disease treatment new hiv drugs phosphodiesterase inhibitors drugs

1.1 million people in the United States are currently infected with HIV, 15 percent of whom do not know they are infected Antiviral "cocktail therapy" can effectively reduce the number of HIV viruse
The State Drug Administration has recently approved the application for registration of the import of the Emmys- and TheU-Z.

 Time of Update: 2020-06-10

direct fuel injection cyclobenzaprine drug interactions spinraza drug hydro drug anti ro antibody

according to the official website of the State Drug Administration, the State Drug (http:// Supervision Authority has recently approved the import registration application for Themesa-Zunad-mono-
Ono Launches Demser250mg Capsules in Japan for Treatment of Patients with Chromoblastoma

 Time of Update: 2020-06-10

united states logo pharmaceutical careers united states pharmacopeia cell capsule

chromosomal cell tumor (PC) is a neuroendocrine tumor that originates in the adrenal myelin or the peripheral nerve section of the adrenal gland, with an estimated 2,920 patients in Japan recently,
FDA accepts new drug application for Lemborexant to treat insomnia

 Time of Update: 2020-06-10

dex drug hazardous drug list vicodin drug mptp drug drug checker

Recently, Japanese drugmaker Eisai and Purdue pharmaceutical (http:// (http:// imbrium Therapeutics announced that the u.S Food and Drug http:// ( FDA ) administration (http:// has accept
Sage's oral innovative antidepressant SAGE-2173 trial ROBIN reached the main and secondary ends of the trial

 Time of Update: 2020-06-10

brain inflammation anxiety what 2 copper lansoprazole 30 mg 1 3 dimethylbutylamine what plaque brain

today, Sage Therapeutics (http:// announced that it had reached the primary and secondary point of the trial in the of the 3-stage trial (http:// ROBIN, a of (http:// for the treatment of wo
FDA accepts Genetec's application for license to supplementary biologics for Tecentriq

 Time of Update: 2020-06-10

which cell kaiser test results 6 mp drug heavy water made positive control biology

lung cancer is the highest incidence and mortality rate in China, including NSCLC accounts for about 80% to 85% of the overall proportion of lung cancer today (January 18), Roche's Genentech compa
EMA grants Krystal Biotech Gene Therapy KB103 for treatment of large herpes epidermal softos

 Time of Update: 2020-06-10

target direct gabapentin drug united process controls belviq drug diphenhydramine drug interactions

recently, krystal Biotech company (http:// announced that the European Medicines (http:// Authority (EMA) has granted its leading candidate gene therapy KB103 (bercolagene telserpavec) priorit
Horizon Pharma announces end of phase 3 trial of the single-eye anti-eye drug teprotumumab treatment TED

 Time of Update: 2020-06-10

igf 1 results sodium test results fgf growth factor nmda receptor antibody test anti citrulline antibody

today, Horizon Pharma announced that it had previously received The FDA's (http:// 's breakthrough therapy determined that orphan drug eligibility and fast-track eligibility in the study of single

Go to Page

Medical Research Articles

European Commission approves head Novartis Luxturna for treatment of hereditary retinal disease

CHMP recommends approval of Tecentriq in combination with amatin and chemotherapy for first-line treatment in Patients with NSq NSCLC

FDA accepts application for license for bioproducts to prevent migraines

Lilly IL-17A inhibitor Taltz (ixekizumab) Phase 3 clinical trial reaches primary endpoint and all important secondary endpoints

FDA approves treatment for multiple peripheral neuropathy -- Onpattro (patisiran)

The smoking cessation drug AXS-05 reaches its main endpoint in the course of smoking cessation

CHMP recommends approval to expand anindications for amp; Aprincyto single-drug treatment

MHLW approves Novartis Kymriah (tisagenlecleucel) for treatment of 2 different indications

FDA accelerates approval of Vitrakvi (larotrectinib) for treatment of late-stage or metastatic solid tumors

Aisi asked EMA for approval of the anti-epileptic drug Fycompa ® (Verumpanai) for the treatment of children with epilepsy

Jansen Pharmaceuticals submits Darzalex (Daratumumab) Class II change request to EMA

FDA approves New Drug Application for Duchesnay Inc. Osphena (aspemifene)

FDA approves launch of antiviral therapy Dovato developed by ViiV Healthcare

The State Drug Administration has recently approved the application for registration of the import of the Emmys- and TheU-Z.

Ono Launches Demser250mg Capsules in Japan for Treatment of Patients with Chromoblastoma

FDA accepts new drug application for Lemborexant to treat insomnia

Sage's oral innovative antidepressant SAGE-2173 trial ROBIN reached the main and secondary ends of the trial

FDA accepts Genetec's application for license to supplementary biologics for Tecentriq

EMA grants Krystal Biotech Gene Therapy KB103 for treatment of large herpes epidermal softos

Horizon Pharma announces end of phase 3 trial of the single-eye anti-eye drug teprotumumab treatment TED